Physician profile
Christopher Shubert
NPI 1164717559
$8,977.52
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2021: $3,330 · 2022: $2,240 · 2023: $644 · 2024: $2,564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,440 · Food and Beverage: $538 · Travel and Lodging: $231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,440.00 |
| Food and Beverage | $537.85 |
| Travel and Lodging | $231.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $3,330.00 | 2021 | |
| Merck Sharp & Dohme LLC | $2,440.00 | 2024 | |
| Fujifilm Healthcare Americas Corporation | $2,240.00 | 2022 | |
| Ethicon US, LLC | $335.79 | 2023-2024 | Neuwave, Echelon Flex, Echelon; Endopath |
| Intuitive Surgical, INC. | $231.00 | 2023 | Da Vinci Surgical System |
| Angiodynamics, INC. | $198.67 | 2019 | |
| Integra Lifesciences Corporation | $153.51 | 2023 | Cusa Clarity, Codman Hakim, Codman Certas |
| Medical Device Business Services, INC. | $48.55 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Shubert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.